Sustained hypoglycemia with therapeutic use of repaglinide
| العنوان: | Sustained hypoglycemia with therapeutic use of repaglinide |
|---|---|
| المؤلفون: | Souleiman El Balkhi, Pierre-François Laterre, Philippe Hantson, Vincent Haufroid |
| المساهمون: | UCL - SSS/IREC/MEDA - Pôle de médecine aiguë, UCL - SSS/IREC/LTAP - Louvain Centre for Toxicology and Applied Pharmacology, UCL - (SLuc) Service de biochimie médicale, UCL - (SLuc) Service de soins intensifs |
| المصدر: | Acta diabetologica, Vol. 57, p. 751–753 (2020) |
| بيانات النشر: | Springer Science and Business Media LLC, 2019. |
| سنة النشر: | 2019 |
| مصطلحات موضوعية: | medicine.medical_specialty, business.industry, Endocrinology, Diabetes and Metabolism, nutritional and metabolic diseases, General Medicine, Hypoglycemia, medicine.disease, Repaglinide, Endocrinology, Diabetes mellitus, Internal Medicine, medicine, Intensive care medicine, business, medicine.drug |
| الوصف: | Repaglinide is a short-acting insulin secretagogue used for the reduction in postprandial glucose levels in diabetic patients. It has a favorable safety profile with a low risk of hypoglycemia. Prolonged hypoglycemia appears exceptional due to the short serum elimination half-life. [...] |
| تدمد: | 1432-5233 0940-5429 |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b03689748989b11066e666d8c892934Test https://doi.org/10.1007/s00592-019-01456-wTest |
| حقوق: | OPEN |
| رقم الانضمام: | edsair.doi.dedup.....3b03689748989b11066e666d8c892934 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 14325233 09405429 |
|---|